Search
for
Sort by
Research 23
- Other Therapies in Vitiligo
- Protoporphyrin IX: the Good, the Bad, and the Ugly
- An Update on Drug-Induced Pigmentation
- Recent therapeutic developments for acne
- Natural Skin Whitening Compounds: Types, Source and Mechanism of Action: A Review
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Hair follicle immune privilege and its collapse in alopecia areata
- Vitiligo - Part 2 - classification, histopathology and treatment
- Frontiers in alopecia areata pathobiology research
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Training requirements and recommendation for the specialty of dermatology and venereology <i>European Standards of Postgraduate Medical Specialist Training</i>
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
- Engineering a New Mouse Model for Vitiligo
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Molecular Targets in Modern Cosmetic Science
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Vitiligo—Current Treatment Options and Future Perspectives
- Medical Therapies